Cargando…

Drugs of abuse and the adolescent athlete

Doping with endocrine drugs is quite prevalent in amateur and professional athletes. The World Anti-Doping Agency (WADA) has a list of banned drugs for athletes who compete and a strategy to detect such drugs. Some are relatively easy, anabolic steroids and erythropoietin, and others more difficult,...

Descripción completa

Detalles Bibliográficos
Autor principal: Rogol, Alan D
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2830221/
https://www.ncbi.nlm.nih.gov/pubmed/20167068
http://dx.doi.org/10.1186/1824-7288-36-19
_version_ 1782178153084485632
author Rogol, Alan D
author_facet Rogol, Alan D
author_sort Rogol, Alan D
collection PubMed
description Doping with endocrine drugs is quite prevalent in amateur and professional athletes. The World Anti-Doping Agency (WADA) has a list of banned drugs for athletes who compete and a strategy to detect such drugs. Some are relatively easy, anabolic steroids and erythropoietin, and others more difficult, human growth hormone (rhGH) and insulin like growth factor I (IGF-I). The use of such compounds is likely less in adolescent athletes, but the detection that much more difficult given that the baseline secretion of the endogenous hormone is shifting during pubertal development with the greatest rise in testosterone in boys occuring about the time of peak height velocity and maximal secretion of hGH and IGF-I. This review notes the rationale, physiology, performance enhancement, adverse events and the detection of doping with insulin, rhGH, rhIGF-I, erythropoietin, and anabolic-androgenic steroids.
format Text
id pubmed-2830221
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28302212010-03-02 Drugs of abuse and the adolescent athlete Rogol, Alan D Ital J Pediatr Review Doping with endocrine drugs is quite prevalent in amateur and professional athletes. The World Anti-Doping Agency (WADA) has a list of banned drugs for athletes who compete and a strategy to detect such drugs. Some are relatively easy, anabolic steroids and erythropoietin, and others more difficult, human growth hormone (rhGH) and insulin like growth factor I (IGF-I). The use of such compounds is likely less in adolescent athletes, but the detection that much more difficult given that the baseline secretion of the endogenous hormone is shifting during pubertal development with the greatest rise in testosterone in boys occuring about the time of peak height velocity and maximal secretion of hGH and IGF-I. This review notes the rationale, physiology, performance enhancement, adverse events and the detection of doping with insulin, rhGH, rhIGF-I, erythropoietin, and anabolic-androgenic steroids. BioMed Central 2010-02-18 /pmc/articles/PMC2830221/ /pubmed/20167068 http://dx.doi.org/10.1186/1824-7288-36-19 Text en Copyright ©2010 Rogol; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Rogol, Alan D
Drugs of abuse and the adolescent athlete
title Drugs of abuse and the adolescent athlete
title_full Drugs of abuse and the adolescent athlete
title_fullStr Drugs of abuse and the adolescent athlete
title_full_unstemmed Drugs of abuse and the adolescent athlete
title_short Drugs of abuse and the adolescent athlete
title_sort drugs of abuse and the adolescent athlete
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2830221/
https://www.ncbi.nlm.nih.gov/pubmed/20167068
http://dx.doi.org/10.1186/1824-7288-36-19
work_keys_str_mv AT rogolaland drugsofabuseandtheadolescentathlete